During a board meeting, Emily Miles outlined how the FSA is proposing to regulate cannabidiol (CBD), with an emphasis on compliance and the requirement that CBD undergo an FSA safety assessment. She stressed that the process would also include updating the public CBD list.
“My message to the CBD industry and to retailers is that you must act responsibly when marketing and selling these products. And my message to the local authorities is that you may need to step up enforcement efforts as products are being rejected by our marketing authorization process. The FSA will assist you in this process, ”said Miles.
There are currently no CBD foods on the market that have completed the mandatory safety assessment and approved for sale. However, it is Public CBD listWill be updated shortly, providing a public record of credible product applications that have been requested for approval.
The list will enable retailers and local authorities in England and Wales to determine the status of CBD foods and decide which enforcements should be given priority.
On behalf of the Board of Directors, Professor Susan Jebb, Chair of the FSA said, “The FSA has a duty to protect consumers. I would like to take this opportunity to ask people to think carefully before taking CBD and to follow the FSA’s advice on CBD products. The FSA will not hesitate to take action if products are found to be unsafe and consumers are at great risk. “
In England and Wales, companies had to submit novel food dossiers to the FSA by March 31st in order for their CBD food products to legally remain on the market.
Applications for approval of these products are required as they are considered “novel foods” and were not consumed before May 1997. These products include CBD oils, nutritional supplements, tablets, and sprays.